South San Francisco, CA — September 28, 2018 — Genentech,
FDA Approves Subcutaneous Formulation of Actemra for Use in Active Systemic Juvenile Idiopathic Arthritis (SJIA)
South San Francisco, CA — September 13, 2018 — Genentech,
allmyfamilycare.com
South San Francisco, CA — September 28, 2018 — Genentech,
South San Francisco, CA — September 13, 2018 — Genentech,